Skip to main content
The Journal of Neuroscience logoLink to The Journal of Neuroscience
. 2015 Jan 21;35(3):1043–1051. doi: 10.1523/JNEUROSCI.2093-14.2015

The Full-Length Form of the Drosophila Amyloid Precursor Protein Is Involved in Memory Formation

Isabelle Bourdet 1, Thomas Preat 1,, Valérie Goguel 1,
PMCID: PMC6605540  PMID: 25609621

Abstract

The APP plays a central role in AD, a pathology that first manifests as a memory decline. Understanding the role of APP in normal cognition is fundamental in understanding the progression of AD, and mammalian studies have pointed to a role of secreted APPα in memory. In Drosophila, we recently showed that APPL, the fly APP ortholog, is required for associative memory. In the present study, we aimed to characterize which form of APPL is involved in this process. We show that expression of a secreted-APPL form in the mushroom bodies, the center for olfactory memory, is able to rescue the memory deficit caused by APPL partial loss of function. We next assessed the impact on memory of the Drosophila α-secretase kuzbanian (KUZ), the enzyme initiating the nonamyloidogenic pathway that produces secreted APPLα. Strikingly, KUZ overexpression not only failed to rescue the memory deficit caused by APPL loss of function, it exacerbated this deficit. We further show that in addition to an increase in secreted-APPL forms, KUZ overexpression caused a decrease of membrane-bound full-length species that could explain the memory deficit. Indeed, we observed that transient expression of a constitutive membrane-bound mutant APPL form is sufficient to rescue the memory deficit caused by APPL reduction, revealing for the first time a role of full-length APPL in memory formation. Our data demonstrate that, in addition to secreted APPL, the noncleaved form is involved in memory, raising the possibility that secreted and full-length APPL act together in memory processes.

Keywords: α-secretase, APPL, Drosophila, kuzbanian, mushroom bodies, short-term memory

Introduction

APP is a major actor of AD (Zheng and Koo, 2011). APP is a transmembrane protein that undergoes two exclusive processing pathways: the nonamyloidogenic pathway initiated by the α-secretase produces a secreted APP form (sAPPα), while the amyloidogenic pathway leads to the production of amyloid-β peptides (Aβ), which can form toxic extracellular deposits in the brain of AD patients (Turner et al., 2003). For years, the amyloid hypothesis has placed Aβ at the center of the pathology etiology (Hardy and Selkoe, 2002).

To understand mechanisms underlying the pathology, it is fundamental to understand the role of APP in normal cognition, especially as disruption of APP normal function may contribute to AD (Neve et al., 2000). AD's first symptom is a decline of episodic memory (Förstl and Kurz, 1999), and several studies in mice reported that sAPPα enhances memory (Meziane et al., 1998; Ring et al., 2007). The physiological role of APP is particularly difficult to study because of its numerous proteolytic metabolites. Furthermore, functional studies of the APP pathway in rodents are limited because of redundancy due to three APP-related genes and the lethality of the triple knock-out (Heber et al., 2000; Herms et al., 2004). In contrast, Drosophila melanogaster expresses a single nonessential APP ortholog, APP-Like (APPL). Importantly, APPL undergoes proteolytic pathways similar to that of APP, and the mammalian homologs of all secretases have been characterized in the fly (Poeck et al., 2012). Despite its relative simplicity, the fly brain is able to drive sophisticated behaviors. Particularly relevant for AD studies, Drosophila is extensively used as a model to study memory, and molecular processes at play are conserved from flies to mammals (McGuire et al., 2005). Neuronal structures underlying olfactory memory are well described. The mushroom bodies (MB), prominent bilateral structures of the fly brain comprising 4000 neurons, have been identified as the center of olfactory learning and memory (Heisenberg, 1998). We have recently shown that APPL is required for memory in the adult MB (Goguel et al., 2011), supporting the hypothesis that APP loss of function might contribute to the appearance of memory deficits in AD.

In the present study, we aimed to characterize which APPL forms are involved in memory. We analyzed short-term memory (STM) after overexpression in the adult MB of either a constitutively secreted APPL form (APPLs; Torroja et al., 1996) or kuzbanian (KUZ), the Drosophila homolog of the mammalian α-secretase ADAM10 (Rooke et al., 1996; Carmine-Simmen et al., 2009). While APPLs overexpression was fully able to rescue the STM deficit caused by an APPL partial loss of function, KUZ overexpression strikingly turned out to exacerbate this deficit. We show that in this context, KUZ overexpression generated a decrease of membrane-bound full-length APPL, and further demonstrate that expression of a membrane-bound mutant form of APPL (Torroja et al., 1996) was sufficient to rescue the STM deficit caused by Appl inhibition. Our data point to a requirement for memory processes of both secreted and nonproteolyzed forms of APPL.

Materials and Methods

Drosophila stocks.

All fly strains were outcrossed to a Canton Special genetic background. The UAS-kuzbanian (kuz) line was kindly provided by D. Kretzschmar (Carmine-Simmen et al., 2009). The Appld;MBSw line was constructed using Appld-null mutant flies (Luo et al., 1992) and the Gal4-inducible MB247-Switch driver (Mao et al., 2004). The deficient Appld w* line used for rescue experiments was a gift from J. M. Dura (Soldano et al., 2013). The UAS-APPL, UAS-APPLs, and UAS-APPLsd lines were described previously (Torroja et al., 1996, 1999). The specific Appl-RNAi used in this study is the transformant #108312 from the Vienna Drosophila RNAi Center. For behavioral experiments, flies were raised on standard medium at 18°C with 60% humidity under a 12 h light/dark cycle. As the Appl gene is located on the X chromosome, only females were analyzed in experiments that involved Appld genotypes. To induce transgene expression, the GeneSwitch system was used as described previously (Mao et al., 2004). A stock solution of RU486 (SPI-Bio; 10 mm in 80% ethanol) was mixed into molten food at 65°C to a final concentration of 200 μm.

Behavior experiments.

Flies were trained with classical olfactory-aversive conditioning protocols as described previously (Pascual and Préat, 2001). One to 2-d-old flies were kept on RU486-containing medium (RU) for 48 h before conditioning, and until testing when performed 24 h later. Training and testing were performed at 25°C with 80% humidity. Conditioning was performed on samples of 30–40 flies with 3-octanol (>95% purity; Fluka 74878, Sigma-Aldrich) and 4-methylcyclohexanol (99% purity; Fluka 66360, Sigma-Aldrich) at 0.360 and 0.325 mm, respectively. Odors were diluted in paraffin oil (VWR International, Sigma-Aldrich). Memory tests were performed with a T-maze apparatus (Tully and Quinn, 1985). Flies could choose for 1 min between two arms, each delivering a distinct odor. An index was calculated as the difference between the numbers of flies in each arm divided by the sum of flies in both arms. A performance index was then reported from the average of two reciprocal experiments with either octanol or methylcyclohexanol as conditioned stimulus. For odor-avoidance tests after electric shock exposure, and response to electric shock, flies were treated as described previously (Pascual and Préat, 2001).

Quantitative PCR.

Flies were raised at 25°C before total RNA extraction from 50 female heads with the RNeasy Plant Mini Kit (Qiagen). Samples were submitted to DNase I treatment (BioLabs), and further reverse transcribed with oligo(dT)20 primers using the SuperScript III First-Strand kit (Life Technologies) according to the manufacturer's instructions. To specifically amplify the Appls cDNA, we used a primer (5′-CGCAGCGAGAAGCTCGATTA-3′) that hybridizes at the site of the stop codon, which was introduced in the Appl sequence to generate the APPLs construct (Torroja et al., 1996). We compared the level of the target cDNA to that of the α-Tub84B (CG1913) cDNA, which was used as a reference. Amplification was performed using a LightCycler 480 (Roche) in conjunction with the SYBR Green I Master (Roche). For each experiment, reactions were performed in triplicate for two dilutions of each cDNA. Each datum represents two to four independent experiments. Specificity and size of amplification products were assessed by melting curve analyses and agarose gel electrophoresis, respectively. Expression relative to the reference is expressed as a ratio (2−ΔCp, where Cp is the crossing point).

Protein analyses.

Proteins were extracted from 140 female fly heads after 48 h of RU induction at 18°C. Protein extracts were fractioned in RIPA buffer containing protease and phosphatase inhibitors (Roche) using sequential centrifugation as described previously (Lallemand et al., 2003). Samples were separated using SDS-PAGE gels containing a gradient of 3–8% acrylamide (Life Technologies) and transferred to nitrocellulose membrane (GE Healthcare). Membranes were cut into two parts and the higher one was probed with anti-APPL that binds to the APPL ectodomain (Ab952M; Torroja et al., 1996) at a dilution of 1:10,000. The lower part of the membrane was probed with either anti-γ-Tub (QG-17; Sigma-Aldrich, dilution 1:20,000) to analyze membrane fractions or anti-α-Tub (T6199; Sigma-Aldrich, 1:40,000 dilution) to analyze soluble fractions. Western blots were routinely developed using the ECL system (Life Technologies). Protein levels were quantified using ImageQuant TL software (GE Healthcare). Following normalization to loading controls, the levels of each APPL-reactive band were expressed as relative to the total amount of APPL detected in heterozygous Appld/+;MBSw/+ flies from the same Western blot experiment. Three independent protein extractions were quantified 10 (membrane fractions) and 11 (soluble fractions) times on four independent Western blots.

Statistical analyses.

Memory scores are displayed as mean ± SEM. To compare performance indexes from more than two groups, statistical analyses were performed through a one-way ANOVA, followed by Newman–Keuls pairwise comparisons. Overall ANOVA p value is given in the legends along with the value of the corresponding Fisher distribution F(x,y), where x is the number of degrees of freedom for groups and y the total number of degrees of freedom for the distribution. Asterisks on the figure represent the least significant of the pairwise post hoc comparisons between the genotype of interest and its controls, following the usual nomenclature. To compare memory scores of two groups, Student's t tests were used with p < 0.05 as a significance threshold. mRNA quantification measurements were analyzed from 2-ΔCp ratios in the same way.

Results

Several reports have shown that APP is involved in memory in mammals. In Drosophila, we recently showed that APPL expression is required in the MB of young adults for long-term memory (LTM) formation (Goguel et al., 2011). Because there are numerous APPL metabolites, we aimed to identify which APPL species are involved in memory processes. To this end, we addressed whether the expression of distinct mutant forms of APPL could rescue the memory deficit observed in flies containing a reduced level of APPL protein.

To analyze memory, we used a classical conditioning of an odor-avoidance response. In this paradigm, groups of flies are successively exposed to two distinct odors, only one of which is associated with electric pulses. Learning and STM are assessed immediately and 2 h, respectively, after one training cycle. Unlike STM, LTM is a consolidated memory whose formation relies on de novo protein synthesis (Tully et al., 1994), and it is assessed 24 h after five-spaced training sessions.

In our previous work (Goguel et al., 2011), we knocked down APPL expression in adult MB by RNAi using the conditional MB247-Switch driver (MBSw; Mao et al., 2004) and UAS-RNAi transgenes. The MBSw driver encodes a Gal4-Switch fusion protein that becomes active when flies are fed with the RU ligand (Roman et al., 2001). However, this knockdown strategy could not be used in the present study, as an Appl RNAi would target both endogenous Appl RNA and that resulting from the construct used to conduct rescue experiments. To circumvent this issue, we took advantage of Appld-null mutant flies (Luo et al., 1992), and generated Appld flies carrying the MBSw driver (Appld;MBSw). As previously described (Luo et al., 1992), homozygous Appld;MBSw flies exhibited an impairment in electric shock avoidance (Fig. 1A), as well as an apparent defect in learning that might result from the impairment in shock reactivity (Fig. 1B). These data are consistent with the fact that Appl deletion leads to subtle abnormal morphology of the MB lobes (Li et al., 2004), and a more recent study showing the role of APPL in brain wiring during development (Soldano et al., 2013). Interestingly, Soldano et al. (2013) showed that Appld/+ heterozygous flies retaining one copy of the Appl wild-type gene do not undergo any MB developmental alteration. We thus hypothesized that Appld/+;MBSw/+ heterozygous flies might constitute a tool to analyze the role of the APPL pathway in memory. As expected, measurement of Appl expression in Appld/+;MBSw/+ fly heads by real-time PCR showed a strong reduction in Appl mRNA levels compared with wild-type (Fig. 1C). Interestingly, and in contrast to the Appld;MBSw-null mutant, Appld/+;MBSw/+ heterozygous flies showed wild-type shock reactivity (Fig. 1D), and also wild-type olfactory acuity (Fig. 1D). Furthermore, Appld/+;MBSw/+ flies displayed a normal learning (Fig. 1E). These data are consistent with the fact that unlike Appld-null mutant, flies expressing 40% of the wild-type level of Appl mRNA possess brain structures involved in olfactory learning and memory that are not affected.

Figure 1.

Figure 1.

APPL LOF induces an STM deficit. A, B, Analysis of Appld;MBSw homozygous flies. A, Appld;MBSw flies exhibit a defect in shock reactivity (t test, **p < 0.005, n = 6). B, Appld;MBSw flies display a learning impairment. To assess learning ability, flies were submitted to one-cycle training and tested immediately after (t test, ***p < 0.0001, n = 8). CG, Analysis of Appld/+;MBSw/+ heterozygous flies. C, qPCR analysis of Appl expression. Total RNA was extracted from wild-type (+) and Appld/+;MBSw/+ fly heads, and further reverse transcribed with oligo(dT) primers. Resulting cDNA was quantified using tubulin (Tub) expression as a reference. Results shown are ratios to the reference (t test, ***p < 0.0001, n = 3). D, Heterozygous Appld/+;MBSw/+ flies display wild-type shock reactivity (t test, p = 0.6622, n = 6) and wild-type olfactory acuity (octanol, t test, p = 0.0954, n = 8; methylcyclohexanol, t test, p = 0.9390, n ≥ 7). E, Learning is not affected. Learning was assessed by testing flies immediately after one-cycle training (t test, p = 0.2717, n ≥ 7). F, Appld/+;MBSw/+ flies exhibit an LTM deficit. To assess LTM, flies were submitted to five-spaced cycles, and memory was tested 24 h later (t test, **p < 0.005, n ≥ 15). G, Appld/+;MBSw/+ flies exhibit an STM deficit. Flies were submitted to one-cycle training and tested 2 h later (t test, *p < 0.05, n ≥ 11). H, Analysis of Appl-RNAi-expressing flies (MBSw/RNAi-108312). Unless indicated (w/o RU), flies were fed with RU for 48 h before conditioning. To assess STM, flies were submitted to one-cycle training and tested 2 h later. MBSw/RNAi-108312 flies exhibit an STM impairment (F(3,47) = 7.507, p = 0.0004, n ≥ 8; Newman–Keuls post hoc, MBSw/RNAi-108312 vs MBSw/+ ***p < 0.001, MBSw/RNAi-108312 vs +/RNAi-108312 **p < 0.005). MBSw/RNAi-108312 flies not fed with RU display performances that were not different from the +/RNAi-108312 control (Newman–Keuls post hoc p > 0.05). Error bars indicate mean ± SEM. PI, Performance Index; OCT, octanol; MCH, methylcyclohexanol.

To better characterize the memory deficit of Appld/+;MBSw/+ heterozygous flies, we analyzed their LTM performances. Consistent with the results previously observed with flies expressing specific Appl RNAi in adult MB (Goguel et al., 2011), Appld/+;MBSw/+ heterozygous flies exhibited an LTM impairment (Fig. 1F). In addition, Appld/+;MBSw/+ heterozygous flies exhibited a slight but significant STM defect compared with wild-type (Fig. 1G), whereas we previously observed that STM was not affected in Appl RNAi-G3- and Appl RNAi-42673-expressing flies (Goguel et al., 2011). In our previous study, APPL protein level was decreased by 39% in the MB as estimated by immunohistochemistry experiments (Goguel et al., 2011), whereas in the present work, Appl mRNA reduction in the fly head estimated by qPCR was 60%, suggesting that APPL protein level in the MB is lower in Appld/+;MBSw/+ heterozygous flies than that previously achieved by RNAi induction. Thus, we hypothesized that the more APPL expression is reduced, the stronger the memory phenotypes observed. Indeed LTM is dependent on more advanced mechanisms than STM and is thus likely more sensitive to disturbance (Dubnau and Tully, 1998). To further address this question, we used a more efficient Appl-RNAi construct (RNAi-108312) to achieve a higher extent of APPL loss of function. Efficiency of Appl RNAi-108312 was assessed by driving its transcription with the pan-neuronal elav-Gal4 driver. qPCR analyses revealed that elav/+;+/RNAi-108312 flies express an Appl/Tub ratio of 0.055 ± 0.003 relative to the elav/+ control, whereas previously published results indicated relative ratios of 0.13 for elav/+;42673/+ and 0.25 for elav/+;G3/+ flies (Goguel et al., 2011), showing that the RNAi-108312 construct leads to a higher Appl knockdown than the RNAi constructs previously used. After 48 h of RU feeding, MBSw/RNAi-108312 flies exhibited an STM deficit (Fig. 1H). This deficit was only observed when flies were fed with RU to induce RNAi expression (Fig. 1H), showing that it is specifically caused by RNAi induction in the adult MB. Therefore, decreasing APPL expression in the MB leads to a slight STM impairment that may not be observed when the reduction of Appl level is less substantial. The memory deficit is thus correlated to the extent of Appl level decrease in the MB. In conclusion, Appld/+;MBSw/+ heterozygous flies should constitute an effective tool to conduct STM rescue experiments in APPL partial loss of function (LOF).

To validate this tool we first expressed the wild-type APPL form and analyzed its capacity to restore the STM deficit of Appld/+;MBSw/+ heterozygous flies. When APPL overexpression was driven in the MB of wild-type flies (MBSw/APPL), it did not alter 2 h memory (Fig. 2A). APPL overexpression in the MB of Appld/+ heterozygous flies (Appld/+;MBSw/APPL) led to a memory score similar to wild-type (Fig. 2B), showing that APPL overexpression in the MB leads to a rescue of the STM deficit caused by the deletion of one of the two copies of the Appl gene. When Appld/+;MBSw/APPL flies were not fed with RU, STM scores were similar to wild-type and to flies of the same genotype fed with RU (Fig. 2B). Thus, we also observe a rescue of the memory deficit in the absence of RU induction. We hypothesized that this phenotype resulted from the expression in the MB of the UAS-APPL transgene, as Gal4-Switch may be partially active in the absence of RU feeding. To assess Appl expression in the absence of RU induction, we performed qPCR analyses. We observed that without induction, Appld/+;MBSw/APPL flies expressed a significant increase in Appl mRNA levels compared with that of Appld/+;+/APPL flies (Fig. 2C). Considering that RNA was extracted from the whole brain, whereas APPL expression due to the activity of the Gal4-Switch was restricted to the MB, APPL level of expression in the MB should be substantial. The memory impairment of Appld/+ flies is very likely caused by a functional deficit in the adult, so we conclude that APPL overexpression rescues the memory deficit caused by a partial reduction of endogenous APPL levels.

Figure 2.

Figure 2.

Expression in the MB of wild-type APPL rescues the memory deficit caused by APPL partial LOF. Unless indicated (B, C, w/o RU), flies were fed with RU for 48 h. A, B, Flies were submitted to one-cycle training, and memory was tested 2 h later. A, MBSw/APPL flies exhibit STM performances similar to control groups (F(3,55) = 2.143, p = 0.1060, n ≥ 11). B, Rescue experiments. Appld/+;MBSw/APPL flies display a score significantly higher than that of Appld/+;+/APPL flies (F(3,84) = 12.88, p = 0.0001, n ≥ 19; Newman–Keuls post hoc, ***p < 0.001), and similar to wild-type (+) control flies (Newman–Keuls post hoc, p > 0.05). Appld/+;MBSw/APPL flies not fed with RU exhibit scores similar to flies of the same genotype fed with RU (Newman–Keuls post hoc, p > 0.05). C, The MBSw driver leads to an increase in Appl levels in the absence of RU induction. Total RNA was extracted from Appld/+;+/APPL and Appld/+;MBSw/APPL fly heads, respectively, and further reverse transcribed. Resulting cDNA was quantified by qPCR using tubulin (Tub) expression as a reference (t test, ***p < 0.0001, n = 4). Error bars indicate mean ± SEM. PI, Performance Index.

As the mammalian secreted fragment produced from the α-secretase cleavage pathway, sAPPα, is the prime candidate for a role in memory (Meziane et al., 1998; Bour et al., 2004; Ring et al., 2007; Taylor et al., 2008), we next aimed to analyze the secreted-APPL form. For this purpose, we took advantage of a constitutively secreted-APPL mutant protein. A stop codon introduced in the Appl sequence generates a 788 aa soluble N-terminal fragment of APPL (APPLs; Torroja et al., 1996), which has been put under control of the UAS expression system to allow for controlled expression patterns (UAS-APPLs; Torroja et al., 1999). To assess APPLs function in memory, we induced its expression in the MB for 48 h before conditioning and analyzed memory performances 2 h after. In flies expressing a wild-type level of endogenous APPL, overexpression of APPLs in the MB (MBSw/APPLs) led to a memory score that was not significantly different from that of control flies (Fig. 3A), showing that expression of a secreted-APPL form in the MB of young adult flies does not increase their STM performances. We next analyzed whether APPLs expression in the MB of APPL partial LOF flies could rescue their STM deficit. Heterozygous Appl/+;MBSw/+ and Appl/+;+/APPLs flies showed an STM deficit (Fig. 3B), while APPLs expression (Appld/+;MBSw/APPLs) led to the restoration of a wild-type STM score (Fig. 3B). This result shows that a secreted form of APPL is involved in memory processes. We observed that Appld/+;MBSw/APPLs flies that were not fed with RU also exhibited a wild-type STM score (Fig. 3B). To assess Appls expression in the absence of RU, we performed qPCR analyses. We observed an intrinsic level of Appls expression in the absence of Gal4 driver (Fig. 3C, Appld/+;+/APPLs). In the presence of the MBSw driver, Appld/+;MBSw/APPLs flies not fed with RU expressed a fivefold increase of Appls mRNA compared with the control (Fig. 3C). This result indicates that in the absence of RU, the Gal4-Switch protein drives expression of the UAS-APPLs transgene. In conclusion, expression of secreted APPL is able to rescue the memory deficit caused by the reduction of endogenous APPL.

Figure 3.

Figure 3.

Expression of secreted APPL rescues the memory deficit caused by APPL partial LOF. Unless indicated (B, C, w/o RU), flies were fed with RU for 48 h. A, B, Flies were submitted to one-cycle training and memory was tested 2 h later. A, APPLs overexpression in the MB does not impact STM. MBSw/APPLs flies exhibit STM performances similar to control groups (F(3,87) = 4.625, p = 0.0048, n ≥ 18; Newman–Keuls post hoc, p > 0.05). +/APPLs flies exhibit an STM score similar to wild-type (+) flies (Newman–Keuls post hoc, p > 0.05). B, Rescue experiments. Appld/+;MBSw/APPLs flies display a score significantly higher than that of Appld/+;MBSw/+ and Appld/+;+/APPLs flies, respectively (F(4,84) = 9.197, p < 0.0001, n ≥ 15; Newman–Keuls post hoc, Appld/+;MBSw/APPLs vs Appld/+;MBSw/+ *p < 0.05, Appld/+;MBSw/APPLs vs Appld/+;+/APPLs **p < 0.005), and similar to wild-type (+) control flies (Newman–Keuls post hoc, p > 0.05). Appld/+;MBSw/APPLs flies not fed with RU exhibit scores similar to flies of the same genotype fed with RU (Newman–Keuls post hoc, p > 0.05). C, APPLs is expressed in the absence of RU feeding. Total RNA was extracted from Appld/+;+/APPLs and Appld/+;MBSw/APPLs fly heads and further reverse transcribed. cDNA resulting specifically from the APPLs construct was quantified by qPCR using tubulin (Tub) expression as a reference (t test, ***p < 0.001, n = 2). Error bars indicate mean ± SEM. PI, Performance Index.

To get further insight into secreted-APPL function in memory, we next analyzed the influence on memory of the overexpression of the Drosophila α-secretase, KUZ (Rooke et al., 1996), the enzyme that initiates the nonamyloidogenic pathway (Carmine-Simmen et al., 2009). Wild-type KUZ-expressing flies (MBSw/kuz) exhibited a memory score that was not significantly different from that of +/kuz control flies (Fig. 4A), showing that, similarly to APPLs, KUZ overexpression in the MB of young adult flies has no impact on STM. We next studied whether overexpression of the α-secretase could rescue the memory deficit caused by APPL partial LOF. Unexpectedly, KUZ-expressing flies (Appl/+;MBSw/kuz) showed an STM score significantly lower than their genetic controls (Fig. 4B). Thus, not only did KUZ overexpression fail to rescue the memory deficit caused by APPL partial LOF, but even more, it exacerbated this deficit. Appl/+;MBSw/kuz flies exhibited similar scores whether or not they were fed with RU for 48 h before conditioning (Fig. 4B). Kuz mRNA quantification indicated that KUZ is overexpressed in the absence of RU feeding (data not shown), showing again that the Gal4-Switch driver is partially active under these conditions. Appl/+;MBSw/kuz flies fed with RU and tested immediately after conditioning exhibited wild-type learning (Fig. 4C). Their ability to avoid electric shocks as well as their olfactory acuity to each odor after electric shock exposure were unaffected (Fig. 4D), showing that they perceived the stimuli used for conditioning normally. These data suggest that brain structures required for olfactory memory are not affected in Appl/+;MBSw/kuz flies.

Figure 4.

Figure 4.

KUZ overexpression exacerbates the memory deficit caused by APPL partial LOF. Unless indicated (B, w/o RU), flies were fed with RU for 48 h before conditioning or total RNA extraction to induce the expression of the UAS-kuz transgene. A, B, Flies were submitted to one-cycle training and tested 2 h later. A, KUZ overexpression in wild-type flies does not impact STM. The score of MBSw/kuz flies is similar to that of the genetic control groups (F(3,90) = 3.342, p = 0.0229, n ≥ 21). B, KUZ overexpression in APPL partial LOF flies exacerbates their STM deficit. Heterozygous Appld/+;MBSw/+ flies exhibit an STM score significantly lower than the wild-type (+) control (F(4,135) = 11.83, p < 0.0001, n ≥ 25; Newman–Keuls post hoc, *p < 0.05). Appld/+;MBSw/kuz flies perform significantly worse than both genetic controls (Newman–Keuls post hoc, *p < 0.05). Appld/+;MBSw/kuz flies not fed with RU display scores significantly different from control groups (Newman–Keuls post hoc, *p < 0.05) and similar to Appld/+;MBSw/kuz flies fed with RU (Newman–Keuls post hoc, p > 0.05). C, Learning is not affected. Learning was assessed by testing flies immediately after one-cycle training. Appld/+;MBSw/kuz flies exhibit scores indistinguishable from controls (F(2,21) = 0.2516, p = 0.7801, n ≥ 7). D, Neither shock reactivity (F(2,42) = 0.3435, p = 0.7113, n ≥ 13) nor olfactory acuity (octanol, F(2,40) = 0.8994, p = 0.4153, n ≥ 9; methylcyclohexanol, F(2,42) = 2.694, p = 0.0798, n ≥ 9) is impaired in Appld/+;MBSw/kuz flies. E, qPCR analysis of kuz expression. Total RNA was extracted from MBSw/kuz and Appld/+;MBSw/kuz fly heads, respectively. Resulting cDNA was quantified using tubulin (Tub) expression as a reference. Results shown are ratios to the reference. kuz mRNA level is similar in MBSw/kuz and Appld/+;MBSw/kuz flies (t test, p = 0.4184, n = 3). Error bars indicate mean ± SEM. PI, Performance Index; OCT, octanol; MCH, methylcyclohexanol.

We next verified the level of kuz overexpression in wild-type and APPL LOF genetic contexts. qPCR analyses revealed that the level of kuz mRNA was similar in MBSw/kuz and Appld/+;MBSw/kuz fly heads (Fig. 4E), indicating that the augmentation of the memory deficit observed in Appld/+;MBSw/kuz flies is not due to an increase in KUZ expression level compared with that of MBSw/kuz flies. Altogether, the data show that in an APPL partial LOF background, overexpression of the α-secretase, KUZ, is deleterious for memory. This result in apparent contradiction to that observed with APPLs overexpression suggests that increasing secreted APPL is not the only consequence of KUZ overexpression.

KUZ has substrates additional to APPL (Pan and Rubin, 1997; Lieber et al., 2002). However, because KUZ overexpression affects STM only when APPL levels are reduced, the results indicate that the memory deficit is caused by an interaction between KUZ and the APPL pathway. To get an insight into this interaction, we first analyzed whether the memory deficit induced by KUZ overexpression in Appld/+;MBSw/kuz flies was linked to a modulation of endogenous Appl expression. Appl mRNA level was similar in Appld/+;MBSw/+ and Appld/+;MBSw/kuz flies (Fig. 5A), showing that the mechanism by which KUZ exacerbates the memory deficit is not through modulation of Appl transcription, but rather through APPL processing. We next analyzed the effect of KUZ overexpression on APPL protein steady-state levels. Western blots were performed after fractionation of fly head lysates. As expected, the data show that APPL-secreted forms revealed in the soluble fraction were enriched upon KUZ overexpression (Fig. 5B). In addition, we observed that full-length APPL (fl-APPL) levels present in the membrane fraction were decreased by 30% in Appld/+;MBSw/kuz compared with Appld/+;MBSw/+ control flies (Fig. 5C). The results thus show that KUZ overexpression leads to a substantial increase of secreted APPL and a concomitant decrease of membrane-bound fl-APPL forms, suggesting that the deleterious impact on memory of the α-secretase overexpression is caused by a decrease of membrane fl-APPL protein.

Figure 5.

Figure 5.

Impact of KUZ overexpression on Appl transcription and APPL processing. Flies were fed with RU for 48 h before RNA or protein extraction. A, qPCR analyses. Total RNA was extracted from Appld/+;MBSw/+ and Appld/+;MBSw/kuz fly heads, and resulting cDNA was quantified using tubulin (Tub) expression as a reference. Results shown are ratios to the reference. Appl mRNA level is similar in Appld/+;MBSw/+ and Appld/+;MBSw/kuz flies (t test, p = 0.5814, n = 3). B, C, Western blot analyses. Protein extracted from fly head lysates was fractionated (n = 3), and resulting blots were stained using an N-ter APPL-specific antibody. Left, Western blots. Right, Quantification. Soluble (n = 11) and membrane (n = 10) species are expressed as ratios to α-Tub and γ-Tub, respectively, relative to the Appld/+;MBSw/+ control. B, Analyses of soluble fractions. Secreted-APPL level is increased in Appld/+;MBSw/kuz flies compared with Appld/+;MBSw/+, while it is not detected in Appld;MBSw-null flies. n.s., Nonspecific band resulting from a cross reaction. C, Analyses of membrane fractions. Left, Dotted lines separate lanes that were run on the same gel, but not side to side. fl-APPL level is decreased in Appld/+;MBSw/kuz flies compared with Appld/+;MBSw/+ control flies. Error bars indicate mean ± SEM.

To get an insight into the influence of fl-APPL on memory, we used the APPLsd (APPL secretion-defective) mutant form of APPL (Torroja et al., 1996, 1999). APPLsd carries a short deletion encompassing the α- and β-cleavage sites that thus prevents its proteolytic cleavage. In consequence, APPLsd is only expressed as a transmembrane protein. When overexpressed for 48 h in the MB of wild-type flies (MBSw/APPLsd), APPLsd mutant form did not affect STM (Fig. 6A). We next overexpressed APPLsd in an APPL partial LOF genetic background. Interestingly, Appld/+;MBSw/APPLsd flies fed with RU showed an STM performance significantly higher than that of Appld/+;MBSw/+ and Appld/+;+/APPLsd flies, and indistinguishable from wild-type (Fig. 6B). In contrast, in the absence of RU-feeding, Appld/+;MBSw/APPLsd flies exhibited scores that were indistinguishable from that of Appld/+;MBSw/+ and Appld/+;+/APPLsd flies, and significantly lower than that of wild-type flies (Fig. 6B).The data show that the induction of APPLsd transient expression in the adult MB rescues the STM defect caused by Appl reduction. This result also demonstrates that the STM deficit observed in Appld/+;MBSw/+ flies (Fig. 1G) is indeed the result of a functional deficit in the adult. In conclusion, APPLsd is able to fully rescue the memory deficit caused by APPL partial LOF, consistent with the fact that KUZ overexpression leads to decreased fl-membrane-bound APPL, and is associated with an exacerbation of memory deficits.

Figure 6.

Figure 6.

Transient expression of membrane-anchored APPLsd rescues the memory deficit caused by APPL partial LOF. Unless indicated (B, w/o RU), flies were fed with RU for 48 h before conditioning. Flies were submitted to one-cycle training and tested 2 h later. A, MBSw/APPLsd flies exhibit STM performances similar to control groups (F(3,39) = 1.693, p = 0.1858, n ≥ 7). B, Appld/+;MBSw/APPLsd flies display a memory score significantly higher than that of Appld/+;MBSw/+ and Appld/+;+/APPLsd flies (F(4,85) = 8.023, p < 0.0001, n ≥ 13; Newman–Keuls post hoc, Appld/+MBSw/APPLsd vs Appld/+;MBSw/+ **p < 0.005, Appld/+MBSw/APPLsd vs Appld/+;+/APPLsd ***p < 0.001), and similar to wild-type (+) flies (Newman–Keuls post hoc, p > 0.05). Appld/+;MBSw/APPLsd flies not fed with RU exhibit scores indistinguishable from that of Appld/+;MBSw/+ and Appld/+;+/APPLsd flies (Newman–Keuls post hoc, p > 0.05), and significantly lower than wild-type (+) (Newman–Keuls post hoc, *p < 0.05). Appld/+;MBSw/APPLsd flies not fed with RU exhibit an STM score significantly decreased compared with the flies of the same genotype fed with RU (Newman–Keuls post hoc, **p < 0.005). Error bars indicate mean ± SEM. PI, Performance Index.

We next aimed to analyze whether the distinct APPL forms used in this study could rescue the LTM deficit caused by the reduction of endogenous APPL levels. As expected, we observed that overexpression of the wild-type APPL form could totally rescue the LTM impairment caused by APPL partial LOF (Fig. 7A). In contrast, neither APPLs nor APPLsd expression could rescue the LTM deficit (Fig. 7B,C). These data thus indicate that overexpression of either secreted APPL or fl-membrane-bound APPL alone is unable to restore wild-type LTM. Although it is difficult to conclude from these negative results, it is possible that both sAPPL and fl-APPL are required for LTM formation, but that either their ratio or their respective abundance is not able to sustain LTM.

Figure 7.

Figure 7.

Analyses of LTM rescue. Flies were fed with RU for 48 h before five-spaced cycle conditioning, and also for 24 h until memory tests. A, Expression of wild-type APPL restores wild-type LTM in Appld/+ heterozygous flies. Appld/+;MBSw/APPL flies exhibit a score significantly higher than that of Appld/+;MBSw/+ and Appld/+;+/APPL flies (F(3,51) = 4.768, p 0.0055, n ≥ 11; Newman–Keuls post hoc, *p < 0.05), and indistinguishable from wild-type (+) flies (Newman–Keuls post hoc, p > 0.05). B, APPLs overexpression does not rescue the LTM deficit caused by APPL partial LOF (F(3,85) = 5.672, p = 0.0014, n ≥ 18). Appld/+;MBSw/APPLs flies display a memory deficit similar to that of Appld/+;MBSw/+ and Appld/+;+/APPLs flies, respectively (Newman–Keuls post hoc, p > 0.05), and significantly lower than wild-type (+) flies (Newman–Keuls post hoc, **p < 0.005). C, APPLsd overexpression does not rescue the LTM deficit caused by APPL partial LOF (F(3,95) = 5.460, p = 0.0017, n ≥ 22). Appld/+;MBSw/APPLsd flies display a memory deficit similar to that of Appld/+;MBSw/+ and Appld/+;+/APPLsd flies (Newman–Keuls post hoc, p > 0.05), and significantly different from that of wild-type (+) flies (Newman–Keuls post hoc, *p < 0.05). Error bars indicate mean ± SEM. PI, Performance Index.

Discussion

The majority of studies into APP biology have focused on pathogenic mechanisms. However, it remains crucial to understand the normal physiological function of APP, especially as it is possible that APP loss of function elicits early cognitive impairment in AD patients. Here, we show that overexpression of secreted APPL rescues the short-term memory deficit caused by a reduction of APPL level. In sharp contrast, overexpression of the α-secretase, KUZ, which produces sAPPL, exacerbates the memory impairment, a phenotype that is likely due to a deficit in full-length APPL protein level. Supporting this hypothesis, we further demonstrate that expression of a nonprocessed APPL mutant form is able to restore wild-type memory in an APPL partial loss of function background.

In the past, two main strategies have been considered as therapeutic approaches for AD. First, inhibition of the β- or γ-secretase has been used to achieve an inhibition of Aβ toxic production (Wolfe, 2008). However, reduction of Aβ production is not only an ineffective approach for AD (Callaway, 2012; Xia et al., 2012), it also can actually promote further pathology, as these enzymes have numerous substrates (Randall et al., 2010). A second proposed approach has been to inhibit the amyloidogenic pathway by activating the α-processing of APP (Fahrenholz, 2007). In addition to the potential beneficial inhibition of the amyloidogenic pathway, the advantage of this type of approach is to also increase the production of sAPPα (Vincent and Govitrapong, 2011). Indeed, decreased CSF sAPPα levels were found in familial and sporadic AD patients (Lannfelt et al., 1995; Sennvik et al., 2000), and correlated with poor memory performance in patients with AD (Almkvist et al., 1997; Fellgiebel et al., 2009). Thus, in vitro and in vivo studies indicate that sAPPα is downregulated during AD. Numerous analyses have shown that sAPPα ectodomain has neurotrophic and neuroprotective effects in different models of neuronal stress (Mattson et al., 1993; Smith-Swintosky et al., 1994; Copanaki et al., 2010; Corrigan et al., 2011). In addition, sAPPα exhibits memory-enhancing properties. Intracerebroventricular infusion of anti-sAPPα serum was deleterious for memory, while that of sAPPα was beneficial (Meziane et al., 1998; Bour et al., 2004; Taylor et al., 2008). However, these studies relied on an exogenous excess of sAPPα and mechanisms of action and potential targets remained to be elucidated. With knock-in mice experiments, Ring et al. (2007) showed that sAPPα was sufficient to correct the impairments in spatial learning and long-term potentiation that are present in APP KO mice. Here we show in Drosophila that sAPPL is able to fully rescue the STM deficit caused by a reduction in endogenous APPL level, thus establishing that an APPL soluble form plays a role in memory, and giving further support for a role of secreted forms in memory in mammal systems.

When the fly α-secretase, KUZ, was overexpressed in the adult MB, we did not observe any STM-enhancing effect and, unexpectedly, KUZ overexpression in the MB of flies with an APPL partial loss of function exacerbated their memory impairment. Thus, KUZ overexpression was actually deleterious for memory, rather than beneficial. These results contrast with a previous study showing that overexpression of the mammalian α-secretase ADAM10 in an AD mice model led to an increase in sAPPα, and was able to overcome APP-related learning deficits (Postina et al., 2004). However, these studies showed that α-secretase activation has a positive impact on memory exclusively under conditions where human APP is overexpressed. In wild-type mice, results were not clear because overexpression of either the wild-type or an inactive form of the bovine ADAM10 altered learning and memory (Schmitt et al., 2006). Furthermore, ADAM10 has many substrates (Vincent and Checler, 2012), and no evidence was brought to link the memory deficit to APP.

Interestingly, we observed that KUZ overexpression decreases membrane nonproteolyzed APPL level, suggesting that its negative impact on memory in APPL LOF flies is linked to a reduction of nonproteolyzed APPL level. Therefore, strategies aimed at increasing APP α-cleavage may not be appropriate as this could provoke a decrease of fl-APP levels that might be deleterious to APP function.

Transient expression of a constitutive membrane-bound mutant APPL has the capacity to fully rescue the STM deficit caused by APPL partial loss of function. Thus, both sAPPL and fl-APPL appear to be involved in memory processes. This is in apparent contradiction with the observation that mammalian sAPPα was sufficient to correct spatial learning deficit of APP KO mice (Ring et al., 2007). However, in this study APP-like proteins APLP1 and ALPL2 were preserved, and as it is known from double KO analyses that the three APP homologs exert functional redundancy (Anliker and Müller, 2006), they may have compensated for the loss of essential fl-APP functions. In consequence, one cannot attribute the memory function exclusively to sAPPα.

If both fl-APPL and sAPPL carry the capacity to restore wild-type STM in APPL partial LOF flies, it is puzzling to observe that KUZ overexpression in this genetic context is deleterious for memory. Indeed, in addition to causing a decrease in fl-APPL, KUZ overexpression leads to a concomitant increase in sAPPL that should be able to complement fl-APPL deficiency. We suggest that in this context, fl-APPL level is below threshold so that even high levels of sAPPL cannot restore a wild-type memory. This hypothesis is supported by protein quantification experiments showing a 30% decrease in fl-APPL level. Because APPL was extracted from the whole brain, whereas KUZ overexpression was only driven in a subset of neurons, the effective fl-APPL decrease in the MB must be much higher than 30%.

In mammalian cells under steady-state levels, ∼10% of APP is located at the plasma membrane (Thinakaran and Koo, 2008). APP has long been suggested to act as a cell-surface receptor (Kang et al., 1987); however, such a function has not been unequivocally established. Several reports have shown that APP exists as homodimers (Scheuermann et al., 2001; Soba et al., 2005; Dahms et al., 2010). Cis-dimerization of APP would represent a potential mechanism for a negative regulation of APP functions and a concomitant impact on Aβ generation via an increase in β-processing (Scheuermann et al., 2001; Hashimoto et al., 2003; Lu et al., 2003; Kedikian et al., 2010; Lefort et al., 2012). Interestingly, it has been suggested that APP is a receptor for sAPPα as its binding could disrupt APP dimers (Gralle et al., 2009).

In Drosophila, Wentzell et al. (2012) reported that the secreted N-terminal ectodomain of APPL acts as a soluble ligand for neuroprotective functions. Furthermore, coimmunoprecipitation experiments from transfected Drosophila MB intrinsic cells revealed a physical interaction between fl-APPL and sAPPL, suggesting that sAPPL could be a ligand for fl-APPL (Wentzell et al., 2012). Our data showing the involvement of both membrane fl-APPL and sAPPL in memory are consistent with the hypothesis that sAPPL could be a ligand for its own fl-APPL precursor.

In conclusion, our data reveal for the first time a role for membrane fl-APPL in memory, opening new questions about APP nonpathological functions and relations between secreted and full-length forms in memory processes.

Footnotes

T.P. was supported by a grant from the French Agence Nationale de la Recherche. I.B. was supported by the Région Ile-de-France. We thank Doris Kretzschmar (Oregon Health and Science University, Portland, OR) and Jean-Maurice Dura (Institut de Génétique Humaine, Montpellier, France) for the kind gift of fly lines. We thank Aurélie Lampin-Saint-Amaux for technical help, and all members of our laboratory for fruitful discussions and critical reading of this manuscript.

The authors declare no competing financial interests.

References

  1. Almkvist O, Basun H, Wagner SL, Rowe BA, Wahlund LO, Lannfelt L. Cerebrospinal fluid levels of alpha-secretase-cleaved soluble amyloid precursor protein mirror cognition in a Swedish family with Alzheimer disease and a gene mutation. Arch Neurol. 1997;54:641–644. doi: 10.1001/archneur.1997.00550170111022. [DOI] [PubMed] [Google Scholar]
  2. Anliker B, Müller U. The functions of mammalian amyloid precursor protein and related amyloid precursor-like proteins. Neurodegener Dis. 2006;3:239–246. doi: 10.1159/000095262. [DOI] [PubMed] [Google Scholar]
  3. Bour A, Little S, Dodart JC, Kelche C, Mathis C. A secreted form of the beta-amyloid precursor protein (sAPP695) improves spatial recognition memory in OF1 mice. Neurobiol Learn Mem. 2004;81:27–38. doi: 10.1016/S1074-7427(03)00071-6. [DOI] [PubMed] [Google Scholar]
  4. Callaway E. Alzheimer's drugs take a new tack. Nature. 2012;489:13–14. doi: 10.1038/489013a. [DOI] [PubMed] [Google Scholar]
  5. Carmine-Simmen K, Proctor T, Tschäpe J, Poeck B, Triphan T, Strauss R, Kretzschmar D. Neurotoxic effects induced by the Drosophila amyloid-β peptide suggest a conserved toxic function. Neurobiol Dis. 2009;33:274–281. doi: 10.1016/j.nbd.2008.10.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Copanaki E, Chang S, Vlachos A, Tschäpe JA, Müller UC, Kögel D, Deller T. sAPPα antagonizes dendritic degeneration and neuron death triggered by proteasomal stress. Mol Cell Neurosci. 2010;44:386–393. doi: 10.1016/j.mcn.2010.04.007. [DOI] [PubMed] [Google Scholar]
  7. Corrigan F, Pham CL, Vink R, Blumbergs PC, Masters CL, van den Heuvel C, Cappai R. The neuroprotective domains of the amyloid precursor protein, in traumatic brain injury, are located in the two growth factor domains. Brain Res. 2011;1378:137–143. doi: 10.1016/j.brainres.2010.12.077. [DOI] [PubMed] [Google Scholar]
  8. Dahms SO, Hoefgen S, Roeser D, Schlott B, Gührs KH, Than ME. Structure and biochemical analysis of the heparin-induced E1 dimer of the amyloid precursor protein. Proc Natl Acad Sci U S A. 2010;107:5381–5386. doi: 10.1073/pnas.0911326107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dubnau J, Tully T. Gene discovery in Drosophila: new insights for learning and memory. Annu Rev Neurosci. 1998;21:407–444. doi: 10.1146/annurev.neuro.21.1.407. [DOI] [PubMed] [Google Scholar]
  10. Fahrenholz F. Alpha-secretase as a therapeutic target. Curr Alzheimer Res. 2007;4:412–417. doi: 10.2174/156720507781788837. [DOI] [PubMed] [Google Scholar]
  11. Fellgiebel A, Kojro E, Müller MJ, Scheurich A, Schmidt LG, Fahrenholz F. CSF APPs alpha and phosphorylated tau protein levels in mild cognitive impairment and dementia of Alzheimer's type. J Geriatr Psychiatry Neurol. 2009;22:3–9. doi: 10.1177/0891988708327810. [DOI] [PubMed] [Google Scholar]
  12. Förstl H, Kurz A. Clinical features of Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci. 1999;249:288–290. doi: 10.1007/s004060050101. [DOI] [PubMed] [Google Scholar]
  13. Goguel V, Belair AL, Ayaz D, Lampin-Saint-Amaux A, Scaplehorn N, Hassan BA, Preat T. Drosophila amyloid precursor protein-like is required for long-term memory. J Neurosci. 2011;31:1032–1037. doi: 10.1523/JNEUROSCI.2896-10.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gralle M, Botelho MG, Wouters FS. Neuroprotective secreted amyloid precursor protein acts by disrupting amyloid precursor protein dimers. J Biol Chem. 2009;284:15016–15025. doi: 10.1074/jbc.M808755200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002;297:353–356. doi: 10.1126/science.1072994. [DOI] [PubMed] [Google Scholar]
  16. Hashimoto Y, Tsuji O, Niikura T, Yamagishi Y, Ishizaka M, Kawasumi M, Chiba T, Kanekura K, Yamada M, Tsukamoto E, Kouyama K, Terashita K, Aiso S, Lin A, Nishimoto I. Involvement of c-Jun N-terminal kinase in amyloid precursor protein-mediated neuronal cell death. J Neurochem. 2003;84:864–877. doi: 10.1046/j.1471-4159.2003.01585.x. [DOI] [PubMed] [Google Scholar]
  17. Heber S, Herms J, Gajic V, Hainfellner J, Aguzzi A, Rülicke T, von Kretzschmar H, von Koch C, Sisodia S, Tremml P, Lipp HP, Wolfer DP, Müller U. Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members. J Neurosci. 2000;20:7951–7963. doi: 10.1523/JNEUROSCI.20-21-07951.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Heisenberg M. What do the mushroom bodies do for the insect brain? An introduction. Learn Mem. 1998;5:1–10. [PMC free article] [PubMed] [Google Scholar]
  19. Herms J, Anliker B, Heber S, Ring S, Fuhrmann M, Kretzschmar H, Sisodia S, Müller U. Cortical dysplasia resembling human type 2 lissencephaly in mice lacking all three APP family members. EMBO J. 2004;23:4106–4115. doi: 10.1038/sj.emboj.7600390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Müller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 1987;325:733–736. doi: 10.1038/325733a0. [DOI] [PubMed] [Google Scholar]
  21. Kedikian G, Heredia F, Salvador VR, Raimunda D, Isoardi N, Heredia L, Lorenzo A. Secreted amyloid precursor protein and holo-APP bind amyloid beta through distinct domains eliciting different toxic responses on hippocampal neurons. J Neurosci Res. 2010;88:1795–1803. doi: 10.1002/jnr.22347. [DOI] [PubMed] [Google Scholar]
  22. Lallemand D, Curto M, Saotome I, Giovannini M, McClatchey AI. NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions. Genes Dev. 2003;17:1090–1100. doi: 10.1101/gad.1054603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lannfelt L, Basun H, Vigo-Pelfrey C, Wahlund LO, Winblad B, Lieberburg I, Schenk D. Amyloid beta-peptide in cerebrospinal fluid in individuals with the Swedish Alzheimer amyloid precursor protein mutation. Neurosci Lett. 1995;199:203–206. doi: 10.1016/0304-3940(95)12059-D. [DOI] [PubMed] [Google Scholar]
  24. Lefort R, Pozueta J, Shelanski M. Cross-linking of cell surface amyloid precursor protein leads to increased β-amyloid peptide production in hippocampal neurons: implications for Alzheimer's disease. J Neurosci. 2012;32:10674–10685. doi: 10.1523/JNEUROSCI.6473-11.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Li Y, Liu T, Peng Y, Yuan C, Guo A. Specific functions of Drosophila amyloid precursor-like protein in the development of nervous system and nonneural tissues. J Neurobiol. 2004;61:343–358. doi: 10.1002/neu.20048. [DOI] [PubMed] [Google Scholar]
  26. Lieber T, Kidd S, Young MW. Kuzbanian-mediated cleavage of Drosophila Notch. Genes Dev. 2002;16:209–221. doi: 10.1101/gad.942302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Lu DC, Soriano S, Bredesen DE, Koo EH. Caspase cleavage of the amyloid precursor protein modulates amyloid beta-protein toxicity. J Neurochem. 2003;87:733–741. doi: 10.1046/j.1471-4159.2003.02059.x. [DOI] [PubMed] [Google Scholar]
  28. Luo L, Tully T, White K. Human amyloid precursor protein ameliorates behavioral deficit of flies deleted for Appl gene. Neuron. 1992;9:595–605. doi: 10.1016/0896-6273(92)90024-8. [DOI] [PubMed] [Google Scholar]
  29. Mao Z, Roman G, Zong L, Davis RL. Pharmacogenetic rescue in time and space of the rutabaga memory impairment by using Gene-Switch. Proc Natl Acad Sci U S A. 2004;101:198–203. doi: 10.1073/pnas.0306128101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Mattson MP, Cheng B, Culwell AR, Esch FS, Lieberburg I, Rydel RE. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein. Neuron. 1993;10:243–254. doi: 10.1016/0896-6273(93)90315-I. [DOI] [PubMed] [Google Scholar]
  31. McGuire SE, Deshazer M, Davis RL. Thirty years of olfactory learning and memory research in Drosophila melanogaster. Prog Neurobiol. 2005;76:328–347. doi: 10.1016/j.pneurobio.2005.09.003. [DOI] [PubMed] [Google Scholar]
  32. Meziane H, Dodart JC, Mathis C, Little S, Clemens J, Paul SM, Ungerer A. Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice. Proc Natl Acad Sci U S A. 1998;95:12683–12688. doi: 10.1073/pnas.95.21.12683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Neve RL, McPhie DL, Chen Y. Alzheimer's disease: a dysfunction of the amyloid precursor protein. Brain Res. 2000;886:54–66. doi: 10.1016/S0006-8993(00)02869-9. [DOI] [PubMed] [Google Scholar]
  34. Pan D, Rubin GM. Kuzbanian controls proteolytic processing of Notch and mediates lateral inhibition during Drosophila and vertebrate neurogenesis. Cell. 1997;90:271–280. doi: 10.1016/S0092-8674(00)80335-9. [DOI] [PubMed] [Google Scholar]
  35. Pascual A, Préat T. Localization of long-term memory within the Drosophila mushroom body. Science. 2001;294:1115–1117. doi: 10.1126/science.1064200. [DOI] [PubMed] [Google Scholar]
  36. Poeck B, Strauss R, Kretzschmar D. Analysis of amyloid precursor protein function in Drosophila melanogaster. Exp Brain Res. 2012;217:413–421. doi: 10.1007/s00221-011-2860-3. [DOI] [PubMed] [Google Scholar]
  37. Postina R, Schroeder A, Dewachter I, Bohl J, Schmitt U, Kojro E, Prinzen C, Endres K, Hiemke C, Blessing M, Flamez P, Dequenne A, Godaux E, van Leuven F, Fahrenholz F. A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. J Clin Invest. 2004;113:1456–1464. doi: 10.1172/JCI20864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Randall AD, Witton J, Booth C, Hynes-Allen A, Brown JT. The functional neurophysiology of the amyloid precursor protein (APP) processing pathway. Neuropharmacology. 2010;59:243–267. doi: 10.1016/j.neuropharm.2010.02.011. [DOI] [PubMed] [Google Scholar]
  39. Ring S, Weyer SW, Kilian SB, Waldron E, Pietrzik CU, Filippov MA, Herms J, Buchholz C, Eckman CB, Korte M, Wolfer DP, Müller UC. The secreted-amyloid precursor protein ectodomain APPs is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-deficient mice. J Neurosci. 2007;27:7817–7826. doi: 10.1523/JNEUROSCI.1026-07.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Roman G, Endo K, Zong L, Davis RL. P[Switch], a system for spatial and temporal control of gene expression in Drosophila melanogaster. Proc Natl Acad Sci U S A. 2001;98:12602–12607. doi: 10.1073/pnas.221303998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Rooke J, Pan D, Xu T, Rubin GM. KUZ, a conserved metalloprotease-disintegrin protein with two roles in Drosophila neurogenesis. Science. 1996;273:1227–1231. doi: 10.1126/science.273.5279.1227. [DOI] [PubMed] [Google Scholar]
  42. Scheuermann S, Hambsch B, Hesse L, Stumm J, Schmidt C, Beher D, Bayer TA, Beyreuther K, Multhaup G. Homodimerization of amyloid precursor protein and its implication in the amyloidogenic pathway of Alzheimer's disease. J Biol Chem. 2001;276:33923–33929. doi: 10.1074/jbc.M105410200. [DOI] [PubMed] [Google Scholar]
  43. Schmitt U, Hiemke C, Fahrenholz F, Schroeder A. Over-expression of two different forms of the alpha-secretase ADAM10 affects learning and memory in mice. Behav Brain Res. 2006;175:278–284. doi: 10.1016/j.bbr.2006.08.030. [DOI] [PubMed] [Google Scholar]
  44. Sennvik K, Fastbom J, Blomberg M, Wahlund LO, Winblad B, Benedikz E. Levels of alpha- and beta-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients. Neurosci Lett. 2000;278:169–172. doi: 10.1016/S0304-3940(99)00929-5. [DOI] [PubMed] [Google Scholar]
  45. Smith-Swintosky VL, Pettigrew LC, Craddock SD, Culwell AR, Rydel RE, Mattson MP. Secreted forms of beta-amyloid precursor protein protect against ischemic brain injury. J Neurochem. 1994;63:781–784. doi: 10.1046/j.1471-4159.1994.63020781.x. [DOI] [PubMed] [Google Scholar]
  46. Soba P, Eggert S, Wagner K, Zentgraf H, Siehl K, Kreger S, Löwer A, Langer A, Merdes G, Paro R, Masters CL, Müller U, Kins S, Beyreuther K. Homo- and heterodimerization of APP family members promotes intercellular adhesion. EMBO J. 2005;24:3624–3634. doi: 10.1038/sj.emboj.7600824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Soldano A, Okray Z, Janovska P, Tmejová K, Reynaud E, Claeys A, Yan J, Atak ZK, De Strooper B, Dura JM, Bryja V, Hassan BA. The Drosophila Homologue of the Amyloid Precursor Protein Is a Conserved Modulator of Wnt PCP Signaling. PLoS Biol. 2013;11:e1001562. doi: 10.1371/journal.pbio.1001562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Taylor CJ, Ireland DR, Ballagh I, Bourne K, Marechal NM, Turner PR, Bilkey DK, Tate WP, Abraham WC. Endogenous secreted amyloid precursor protein-alpha regulates hippocampal NMDA receptor function, long-term potentiation and spatial memory. Neurobiol Dis. 2008;31:250–260. doi: 10.1016/j.nbd.2008.04.011. [DOI] [PubMed] [Google Scholar]
  49. Thinakaran G, Koo EH. Amyloid precursor protein trafficking, processing, and function. J Biol Chem. 2008;283:29615–29619. doi: 10.1074/jbc.R800019200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Torroja L, Luo L, White K. APPL, the Drosophila member of the APP-family, exhibits differential trafficking and processing in CNS neurons. J Neurosci. 1996;16:4638–4650. doi: 10.1523/JNEUROSCI.16-15-04638.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Torroja L, Packard M, Gorczyca M, White K, Budnik V. The Drosophila beta-amyloid precursor protein homolog promotes synapse differentiation at the neuromuscular junction. J Neurosci. 1999;19:7793–7803. doi: 10.1523/JNEUROSCI.19-18-07793.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Tully T, Quinn WG. Classical conditioning and retention in normal and mutant Drosophila melanogaster. J Comp Physiol A. 1985;157:263–277. doi: 10.1007/BF01350033. [DOI] [PubMed] [Google Scholar]
  53. Tully T, Preat T, Boynton SC, Del Vecchio M. Genetic dissection of consolidated memory in Drosophila. Cell. 1994;79:35–47. doi: 10.1016/0092-8674(94)90398-0. [DOI] [PubMed] [Google Scholar]
  54. Turner PR, O'Connor K, Tate WP, Abraham WC. Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog Neurobiol. 2003;70:1–32. doi: 10.1016/S0301-0082(03)00089-3. [DOI] [PubMed] [Google Scholar]
  55. Vincent B, Checler F. α-Secretase in Alzheimer's disease and beyond: mechanistic, regulation and function in the shedding of membrane proteins. Curr Alzheimer Res. 2012;9:140–156. doi: 10.2174/156720512799361646. [DOI] [PubMed] [Google Scholar]
  56. Vincent B, Govitrapong P. Activation of the α-secretase processing of AβPP as a therapeutic approach in Alzheimer's disease. J Alzheimers Dis. 2011;24(Suppl 2):75–94. doi: 10.3233/JAD-2011-110218. [DOI] [PubMed] [Google Scholar]
  57. Wentzell JS, Bolkan BJ, Carmine-Simmen K, Swanson TL, Musashe DT, Kretzschmar D. Amyloid precursor proteins are protective in Drosophila models of progressive neurodegeneration. Neurobiol Dis. 2012;46:78–87. doi: 10.1016/j.nbd.2011.12.047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Wolfe MS. Selective amyloid-β lowering agents. BMC Neurosci. 2008;9:S4. doi: 10.1186/1471-2202-9-S2-S4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Xia W, Wong ST, Hanlon E, Morin P. γ-Secretase modulator in Alzheimer's disease: shifting the end. J Alzheimers Dis. 2012;31:685–696. doi: 10.3233/JAD-2012-120751. [DOI] [PubMed] [Google Scholar]
  60. Zheng H, Koo EH. Biology and pathophysiology of the amyloid precursor protein. Mol Neurodegener. 2011;6:27. doi: 10.1186/1750-1326-6-27. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Neuroscience are provided here courtesy of Society for Neuroscience

RESOURCES